TME Pharma N.V. (ALTME.PA)
EUR 0.06
(1.1%)
EUR 0.06
(1.1%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 91 Thousand EUR | 22.97% |
| 2022 | 74 Thousand EUR | -40.32% |
| 2021 | 124 Thousand EUR | -16.78% |
| 2020 | 149 Thousand EUR | 36.7% |
| 2019 | 109 Thousand EUR | 4.81% |
| 2018 | 104 Thousand EUR | 0.0% |
| 2017 | - EUR | 100.0% |
| 2016 | -128 Thousand EUR | -1084.62% |
| 2015 | 13 Thousand EUR | -65.79% |
| 2014 | 38 Thousand EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | - EUR | 0.0% |
| 2023 FY | 91 Thousand EUR | 22.97% |
| 2023 Q4 | - EUR | 0.0% |
| 2023 Q3 | - EUR | 0.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2023 Q2 | - EUR | 0.0% |
| 2022 Q3 | - EUR | 0.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2022 Q2 | - EUR | 0.0% |
| 2022 FY | 74 Thousand EUR | -40.32% |
| 2022 Q4 | 74 Thousand EUR | 0.0% |
| 2021 Q2 | - EUR | 0.0% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q4 | 124 Thousand EUR | 0.0% |
| 2021 FY | 124 Thousand EUR | -16.78% |
| 2021 Q3 | - EUR | 0.0% |
| 2020 Q4 | 149 Thousand EUR | 0.0% |
| 2020 FY | 149 Thousand EUR | 36.7% |
| 2020 Q2 | - EUR | 0.0% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q3 | - EUR | 0.0% |
| 2019 Q4 | 109 Thousand EUR | 0.0% |
| 2019 FY | 109 Thousand EUR | 4.81% |
| 2019 Q3 | - EUR | 0.0% |
| 2019 Q2 | - EUR | 0.0% |
| 2019 Q1 | - EUR | 0.0% |
| 2018 Q3 | - EUR | 0.0% |
| 2018 Q4 | - EUR | 0.0% |
| 2018 FY | 104 Thousand EUR | 0.0% |
| 2018 Q1 | - EUR | 0.0% |
| 2018 Q2 | - EUR | 0.0% |
| 2017 Q3 | - EUR | 0.0% |
| 2017 FY | - EUR | 100.0% |
| 2017 Q1 | - EUR | 0.0% |
| 2017 Q2 | - EUR | 0.0% |
| 2017 Q4 | - EUR | 0.0% |
| 2016 Q1 | 5000.00 EUR | -61.54% |
| 2016 Q3 | - EUR | -100.0% |
| 2016 Q4 | - EUR | 0.0% |
| 2016 FY | -128 Thousand EUR | -1084.62% |
| 2016 Q2 | 5000.00 EUR | 0.0% |
| 2015 FY | 13 Thousand EUR | -65.79% |
| 2015 Q4 | 13 Thousand EUR | 0.0% |
| 2015 Q3 | 13 Thousand EUR | 0.0% |
| 2015 Q1 | - EUR | 0.0% |
| 2014 FY | 38 Thousand EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| ABIONYX Pharma SA | 221 Thousand EUR | 58.824% |
| ABIVAX Société Anonyme | 1.00 EUR | -9099900.0% |
| Adocia SA | 272 Thousand EUR | 66.544% |
| Aelis Farma SA | 53 Thousand EUR | -71.698% |
| Biophytis S.A. | - EUR | -Infinity% |
| Advicenne S.A. | 1.74 Million EUR | 94.773% |
| genOway Société anonyme | 982.75 Thousand EUR | 90.74% |
| IntegraGen SA | 311.44 Thousand EUR | 70.782% |
| Medesis Pharma S.A. | 164.62 Thousand EUR | 44.722% |
| Neovacs S.A. | - EUR | -Infinity% |
| NFL Biosciences SA | -1.1 Million EUR | 108.208% |
| Plant Advanced Technologies SA | 1.22 Million EUR | 92.569% |
| Quantum Genomics Société Anonyme | -119.17 Thousand EUR | 176.358% |
| Sensorion SA | - EUR | -Infinity% |
| Theranexus Société Anonyme | - EUR | -Infinity% |
| Valbiotis SA | 1 Million EUR | 90.945% |
| TheraVet SA | 123.34 Thousand EUR | 26.221% |
| Valerio Therapeutics Société anonyme | 1.00 EUR | -9099900.0% |
| argenx SE | 281.12 Million EUR | 99.968% |
| BioSenic S.A. | - EUR | -Infinity% |
| Celyad Oncology SA | 1.26 Million EUR | 92.778% |
| DBV Technologies S.A. | 1.00 USD | -9099900.0% |
| Galapagos NV | 73.97 Million EUR | 99.877% |
| Genfit S.A. | 4000.00 EUR | -2175.0% |
| GeNeuro SA | - EUR | -Infinity% |
| Hyloris Pharmaceuticals SA | 1.00 EUR | -9099900.0% |
| Innate Pharma S.A. | 1.00 EUR | -9099900.0% |
| Inventiva S.A. | 417 Thousand EUR | 78.177% |
| MaaT Pharma SA | 190 Thousand EUR | 52.105% |
| MedinCell S.A. | -6.71 Million EUR | 101.355% |
| Nanobiotix S.A. | 200 Thousand EUR | 54.5% |
| Onward Medical N.V. | 936 Thousand EUR | 90.278% |
| Oryzon Genomics S.A. | 6029.00 EUR | -1409.371% |
| OSE Immunotherapeutics SA | - EUR | -Infinity% |
| Oxurion NV | 128 Thousand EUR | 28.906% |
| Pharming Group N.V. | 51.38 Million EUR | 99.823% |
| Poxel S.A. | 2.95 Million EUR | 96.922% |
| GenSight Biologics S.A. | 1.00 EUR | -9099900.0% |
| Transgene SA | - EUR | -Infinity% |
| Financière de Tubize SA | - EUR | -Infinity% |
| UCB SA | 1.03 Billion EUR | 99.991% |
| Valneva SE | 44.46 Million EUR | 99.795% |
| Vivoryon Therapeutics N.V. | 1.00 EUR | -9099900.0% |